Atlas Trials

Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

Clinical trial NCT02241590 · UNKNOWN

Trial details

NCT number
NCT02241590
Sponsor
ShuGuang Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Cirrhosis Due to Hepatitis B Virus
Start date
2014-09-01
Primary completion
2019-06-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.